About SPDR S&P Biotech (NYSEARCA:XBI)
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.
Industry, Sector and Symbol:
- Sector: Financials
- Industry: Exchange Traded Funds
- Sub-Industry: N/A
- Symbol: NYSEARCA:XBI
- CUSIP: N/A
- Web: https://www.spdrs.com/
- 50 Day Moving Avg: $85.47
- 200 Day Moving Avg: $76.73
- 52 Week Range: $53.15 - $88.98
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Net Margins: 3,150.61%
- Return on Equity: 40.83%
- Return on Assets: 32.53%
- Average Volume: 3.45 million shs.
Frequently Asked Questions for SPDR S&P Biotech (NYSEARCA:XBI)
What is SPDR S&P Biotech's stock symbol?
SPDR S&P Biotech trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."
How often does SPDR S&P Biotech pay dividends? What is the dividend yield for SPDR S&P Biotech?
SPDR S&P Biotech announced a quarterly dividend on Friday, September 15th. Stockholders of record on Monday, September 18th will be given a dividend of $0.037 per share on Monday, September 25th. This represents a $0.15 annualized dividend and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, September 15th. View SPDR S&P Biotech's Dividend History.
Who are some of SPDR S&P Biotech's key competitors?
Some companies that are related to SPDR S&P Biotech include Berkshire Hathaway (BRK.B), Wells Fargo & Co (WFC), HSBC Holdings plc (HSBA), Banco Bilbao Vizcaya Argentaria SA (BBVA), Prudential plc (PRU), Capital One Financial Corp. (COF), Lloyds Banking Group PLC (LLOY), State Street Corp (STT), Royal Bank of Scotland Group plc (RBS), Barclays PLC (BARC), Standard Chartered PLC (STAN), AvalonBay Communities (AVB), Aviva plc (AV), Credicorp (BAP), Legal & General Group Plc (LGEN), Banco Santander-Chile (BSAC), London Stock Exchange Group Plc (LSE) and Standard Life Aberdeen PLC (SLA).
Who are SPDR S&P Biotech's key executives?
SPDR S&P Biotech's management team includes the folowing people:
- James E. Ross, President, Trustee
- Peter A. Ambrosini, Chief Compliance Officer
- Michael P. Riley, Vice President
- Gary L. French, Treasurer
- John W. Clark, Assistant Treasurer
- Matthew W. Flaherty, Assistant Treasurer
- Chad C. Hallett, Assistant Treasurer of Street tracks series trust
- Mary Moran Zeven, Secretary
- Scott M. Zoltowski, Assistant Secretary
- Dave Kelly, Independent Trustee
Who owns SPDR S&P Biotech stock?
SPDR S&P Biotech's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Guild Investment Management Inc. (0.00%) and Moloney Securities Asset Management LLC (0.00%). View Institutional Ownership Trends for SPDR S&P Biotech.
Who bought SPDR S&P Biotech stock? Who is buying SPDR S&P Biotech stock?
How do I buy SPDR S&P Biotech stock?
Shares of SPDR S&P Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SPDR S&P Biotech's stock price today?
MarketBeat Community Rating for SPDR S&P Biotech (NYSEARCA XBI)MarketBeat's community ratings are surveys of what our community members think about SPDR S&P Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of SPDR S&P Biotech stock can currently be purchased for approximately $85.62.
Consensus Ratings for SPDR S&P Biotech (NYSEARCA:XBI) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for SPDR S&P Biotech (NYSEARCA:XBI)
Analysts' Ratings History for SPDR S&P Biotech (NYSEARCA:XBI)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for SPDR S&P Biotech (NYSEARCA:XBI)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History by Quarter for SPDR S&P Biotech (NYSEARCA XBI)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for SPDR S&P Biotech (NYSEARCA:XBI)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for SPDR S&P Biotech (NYSEARCA:XBI)
Latest Headlines for SPDR S&P Biotech (NYSEARCA:XBI)
SPDR S&P Biotech (XBI) Chart for Saturday, October, 21, 2017